SYT1 and Alzheimer disease: demonstrated that a number of proteins, such as growth-associated protein 43 (GAP43), neurogranin, synaptosome-associated protein 25 (SNAP25), and synaptotagmin 1, were markedly reduced in EVs from patients with AD compared with controls.85